Evidence map›Paper›PMID 20143235›Full record

ArticleInternational journal of colorectal disease2010

Impact of using elastic stains for detection of venous invasion in the prognosis of patients with lymph node negative colorectal cancer.

Daniel Baumhoer, Thore Thiesler, Christoph A Maurer, Andreas Huber, Gieri Cathomas

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Daniel BaumhoerCantonal Institute for Pathology, Cantonal Hospital Liestal, Mühlemattstrasse 11, 4410 Liestal, Switzerland.
Thore Thiesler
Christoph A Maurer
Andreas Huber
Gieri Cathomas
Kantonsspital Baselland Standort Bruderholz · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PURPOSE AND

methodsPatients with nodal negative colorectal cancer (CRC) suffer recurrent or metastatic disease in 40% of cases after surgical resection. To investigate a potential prognostic impact of vascular tumor infiltration, we retrospectively analyzed 185 nodal negative stage I and II CRC specimens for the presence of intra- and/or extramural venous invasion (V1IM/V1EM) using elastic stains of all tumor sections and correlated our findings with the clinical follow-up.

resultsVenous invasion was observed in 43 (23.2%) patients by elastic stains compared with six (3.2%) using HE only (p < 0.05). Venous invasion was more common in stage II than in stage I tumors (28.1% versus 5.1%; p < 0.05). However, survival analyses showed no significant differences in 5-year survival rates comparing patients with and without venous invasion (68% and 71%, p = 0.543) or patients with V1IM and V1EM (62% vs. 74%, p = 0.473), respectively.

conclusionsOur data emphasize the need for standardized criteria, including elastic stains, to reliably detect vascular invasion in CRC. Doing so, however, the prognostic impact of venous invasion in stage I and II CRC may be lower as previously anticipated.

Indexed as

Coloring AgentsAdultAgedAged, 80 and overColorectal NeoplasmsFemaleHumansKaplan-Meier EstimateLymph NodesMaleMiddle AgedNeoplasm InvasivenessPrognosisVeinsColoring Agents

Identifiers

PMID20143235
OpenAlexW2147427761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.